In conclusion, molecules such as RUNX2, CBX3, and MYC interact with YBX1 to promote tumor progression in various malignant tumors, including bone cancer, pancreatic cancer, and rhabdomyosarcoma, among others. This evidence concerns the gene MYC and rhabdomyosarcoma.